209 related articles for article (PubMed ID: 30801742)
1. Antimalarial drugs and their metabolites are potent Zika virus inhibitors.
Han Y; Pham HT; Xu H; Quan Y; Mesplède T
J Med Virol; 2019 Jul; 91(7):1182-1190. PubMed ID: 30801742
[TBL] [Abstract][Full Text] [Related]
2. The antimalarial drug amodiaquine possesses anti-ZIKA virus activities.
Han Y; Mesplède T; Xu H; Quan Y; Wainberg MA
J Med Virol; 2018 May; 90(5):796-802. PubMed ID: 29315671
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
[TBL] [Abstract][Full Text] [Related]
4. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
5. Anti-zika virus activity of polyoxometalates.
Francese R; Civra A; Rittà M; Donalisio M; Argenziano M; Cavalli R; Mougharbel AS; Kortz U; Lembo D
Antiviral Res; 2019 Mar; 163():29-33. PubMed ID: 30653996
[TBL] [Abstract][Full Text] [Related]
6. Nucleoside Inhibitors of Zika Virus.
Eyer L; Nencka R; Huvarová I; Palus M; Joao Alves M; Gould EA; De Clercq E; Růžek D
J Infect Dis; 2016 Sep; 214(5):707-11. PubMed ID: 27234417
[TBL] [Abstract][Full Text] [Related]
7. Cell-line dependent antiviral activity of sofosbuvir against Zika virus.
Mumtaz N; Jimmerson LC; Bushman LR; Kiser JJ; Aron G; Reusken CBEM; Koopmans MPG; van Kampen JJA
Antiviral Res; 2017 Oct; 146():161-163. PubMed ID: 28912011
[TBL] [Abstract][Full Text] [Related]
8. Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication.
Cai L; Sun Y; Song Y; Xu L; Bei Z; Zhang D; Dou Y; Wang H
Arch Virol; 2017 Sep; 162(9):2847-2853. PubMed ID: 28597088
[TBL] [Abstract][Full Text] [Related]
9. Favipiravir and Ribavirin Inhibit Replication of Asian and African Strains of Zika Virus in Different Cell Models.
Kim JA; Seong RK; Kumar M; Shin OS
Viruses; 2018 Feb; 10(2):. PubMed ID: 29425176
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice.
Kamiyama N; Soma R; Hidano S; Watanabe K; Umekita H; Fukuda C; Noguchi K; Gendo Y; Ozaki T; Sonoda A; Sachi N; Runtuwene LR; Miura Y; Matsubara E; Tajima S; Takasaki T; Eshita Y; Kobayashi T
Antiviral Res; 2017 Oct; 146():1-11. PubMed ID: 28818572
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models.
Delvecchio R; Higa LM; Pezzuto P; Valadão AL; Garcez PP; Monteiro FL; Loiola EC; Dias AA; Silva FJ; Aliota MT; Caine EA; Osorio JE; Bellio M; O'Connor DH; Rehen S; de Aguiar RS; Savarino A; Campanati L; Tanuri A
Viruses; 2016 Nov; 8(12):. PubMed ID: 27916837
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus.
Zhang S; Yi C; Li C; Zhang F; Peng J; Wang Q; Liu X; Ye X; Li P; Wu M; Yan Q; Guo W; Niu X; Feng L; Pan W; Chen L; Qu L
Antiviral Res; 2019 Sep; 169():104547. PubMed ID: 31251958
[TBL] [Abstract][Full Text] [Related]
14. Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.
Zhang JW; Wang H; Liu J; Ma L; Hua RH; Bu ZG
Virol Sin; 2021 Jun; 36(3):476-489. PubMed ID: 33231855
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
16. A synthetic derivative of houttuynoid B prevents cell entry of Zika virus.
Basic M; Elgner F; Bender D; Sabino C; Herrlein ML; Roth H; Glitscher M; Fath A; Kerl T; Schmalz HG; Hildt E
Antiviral Res; 2019 Dec; 172():104644. PubMed ID: 31697958
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors.
Wang Y; Zhou R; Quan Y; Chen S; Shi X; Li Y; Cen S
Bioorg Med Chem Lett; 2020 Feb; 30(4):126906. PubMed ID: 31902708
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Zika Virus Infection and Replication in Endothelial Cells and Astrocytes by PKA Inhibitor PKI 14-22.
Cheng F; Ramos da Silva S; Huang IC; Jung JU; Gao SJ
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212931
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
Vicenti I; Boccuto A; Giannini A; Dragoni F; Saladini F; Zazzi M
Virus Res; 2018 Jan; 244():64-70. PubMed ID: 29113824
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
